Association between e-cigarette exposure and ventilation homogeneity in young adults: a cross-sectional study
- PMID: 39603668
- PMCID: PMC11948420
- DOI: 10.1183/13993003.01675-2024
Association between e-cigarette exposure and ventilation homogeneity in young adults: a cross-sectional study
Abstract
Background: The number of young people who use e-cigarettes is rising. It remains unclear whether e-cigarette use impairs lung function. We aimed to compare ventilation distribution between young adults exposed to e-cigarettes and an unexposed group.
Methods: Study participants included otherwise healthy young adults (18-24 years) who self-reported e-cigarette use and unexposed participants who had no history of e-cigarette, tobacco or cannabis exposure. Exposure to e-cigarettes was defined using three measures: 1) ever-exposed, 2) daily use and 3) puff frequency, which includes none (unexposed), minimal (<2 puffs·h-1), moderate (3-4 puffs·h-1) and heavy (≥5 puffs·h-1). Ventilation distribution was measured using the multiple-breath washout test and reported as lung clearance index (LCI).
Results: A total of 93 participants were recruited; 38 unexposed and 41 exposed participants had LCI measures. The exposed group consisted predominately of participants who used flavoured e-liquids (94.5%) that contained nicotine (93.5%). The magnitude and direction of the difference in LCI across the exposure definitions was similar. Compared with the unexposed group, in the unadjusted models LCI was higher in those with any e-cigarette use (mean difference 0.15, 95% CI -0.004-0.31), daily users (mean difference 0.10, 95% CI -0.08-0.28) and heavy users (mean difference 0.22, 95% CI 0.03-0.41).
Conclusion: This preliminary work suggests that LCI may be a useful biomarker to measure the effects of e-cigarette use on ventilation distribution and to track early functional impairment of the small airways.
Copyright ©The authors 2025.
Conflict of interest statement
Conflict of interest: S. Stanojevic reports grants from the ATS (Chair: ATS/ERS Updated Technical Standard on PFT interpretation), consulting fees from Chiesi Farmaceutici, speaker fees from Vyaire Medical, participation on a medical advisory board with Ndd Technologies, leadership roles with the ATS (Pulmonary Function Testing Committee) and ERS (Global Lung Function Initiative), and other non-financial interests as a statistical editor for Thorax, editorial board member for the European Respiratory Journal, and junior associate editor for the Canadian Journal of Respiratory, Critical Care and Sleep Medicine. The remaining authors have no potential conflicts of interest to disclose.
Figures


Comment in
-
Vaping and lung health: less known unknowns.Eur Respir J. 2025 Mar 27;65(3):2402482. doi: 10.1183/13993003.02482-2024. Print 2025 Mar. Eur Respir J. 2025. PMID: 40147858 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical